Healthcare Equipment and Supplies
Company Overview of Singulex, Inc.
Singulex, Inc. develops and manufactures immunodiagnostic products. It provides immunoassay systems, which includes benchtop analytical instrumentation, integrated and prepared reagents for ultrasensitive immunoassays, and software to automatically analyze data and display detailed assay reports. The company also offers molecule counting products; ultrasensitive immunoassays, such as inflammation, cardiovascular, neurology, oncology, metabolism, and toxicity; SgxHD for cardiovascular monitoring; and custom services and support, such as sample testing, assay development, and antibody derivatization. Singulex, Inc. was formerly known as BioProfile Corporation and changed its name to Singulex, ...
1650 Harbor Bay Parkway
Alameda, CA 94502
Founded in 1997
Key Executives for Singulex, Inc.
Chief Executive Officer, President and Director
Chief Financial Officer and Principal Accounting Officer
Chief Commercial Officer and Senior Vice President of Sales & Marketing
Vice President of Business Development
Compensation as of Fiscal Year 2014.
Singulex, Inc. Key Developments
Singulex Announces Collaboration with CHDI Foundation to Develop Biomarker Assays for Huntington's Disease
Apr 9 15
Singulex, Inc. announced a collaboration agreement with CHDI Foundation. The collaboration will use Singulex's proprietary Erenna Immunoassay System to develop biomarkers to further Huntington's disease research. The Singulex assay combines fluorescent antibodies with a laser detection chamber to count individual molecules of mHTT with a very low detection threshold, including both high specificity for mHTT and sensitivity to the femtomolar level.
Health Diagnostics Laboratory Inc and Singulex, Inc. Labs to Pay $48.5 Million to Settle Doctor's Whistleblower Case
Apr 9 15
Health Diagnostics Laboratory Inc. and Singulex Inc. have agreed to resolve allegations that they violated the False Claims Act by paying remuneration to physicians in exchange for patient referrals and billing federal health care programs for medically unnecessary testing, the U.S. Department of Justice. Under the settlements, which stem from three related whistleblower actions filed under the federal False Claims Act, HDL will pay $47 million and Singulex will pay $1.5 million.
Singulex, Inc. Announces Expansion of National Sales Force for Clinical Lab Business; Appoints Anthony Facinelli as Vice President, Clinical Lab Testing Services Sales and Marketing
Oct 21 14
Singulex, Inc. outlined a refinement of the company's commercial strategy which will expand its Clinical Lab Testing Services direct sales force throughout the United States.
As part of the refinement of its commercial strategy, Singulex recently hired Anthony Facinelli as Vice President, Clinical Lab Testing Services Sales and Marketing, to lead the commercial growth of the Clinical Lab business. Mr. Facinelli has over twenty years of executive management experience in the clinical lab and diagnostics sectors. Previously, Mr. Facinelli held various executive positions with Quest Diagnostics, including Regional Vice President Sales and senior sales and marketing roles with companies such as Lab Corp, PathNet and Specialty Laboratories.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|